Irvine Firm Receives Grant for Tumor Study
- Share via
(Dow Jones)
Irvine-based Nexell Therapeutics Inc. said Monday it received a $535,000 grant from the National Institutes of Health and will begin a two-year tumor-cell study.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
